Rigel Pharmaceuticals (RIGL) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.06% |
| Dec 31, 2025 | -37.48% |
| Sep 30, 2025 | -29.90% |
| Jun 30, 2025 | -34.78% |
| Mar 31, 2025 | -19.45% |
| Dec 31, 2024 | -7.46% |
| Sep 30, 2024 | 71.72% |
| Jun 30, 2024 | 22.38% |
| Mar 31, 2024 | 18.04% |
| Dec 31, 2023 | -39.51% |
| Sep 30, 2023 | -15.71% |
| Jun 30, 2023 | 16.90% |
| Mar 31, 2023 | -49.31% |
| Dec 31, 2022 | 20.38% |
| Sep 30, 2022 | 6.70% |
| Jun 30, 2022 | 20.35% |
| Mar 31, 2022 | 173.44% |
| Dec 31, 2021 | 25.18% |
| Sep 30, 2021 | -44.37% |
| Jun 30, 2021 | -35.65% |
| Mar 31, 2021 | 25.49% |
| Dec 31, 2020 | -7.34% |
| Sep 30, 2020 | -8.62% |
| Jun 30, 2020 | 8.80% |
| Mar 31, 2020 | 20.80% |
| Dec 31, 2019 | -19.63% |
| Sep 30, 2019 | -15.33% |
| Jun 30, 2019 | -20.30% |
| Mar 31, 2019 | -16.02% |
| Dec 31, 2018 | -38.35% |
| Sep 30, 2018 | 1.24% |
| Jun 30, 2018 | -31.78% |
| Mar 31, 2018 | -2.08% |
| Dec 31, 2017 | 20.11% |
| Sep 30, 2017 | -16.90% |
| Jun 30, 2017 | -19.01% |
| Mar 31, 2017 | -14.94% |
| Dec 31, 2016 | -34.74% |
| Sep 30, 2016 | 23.76% |
| Jun 30, 2016 | 16.86% |
| Mar 31, 2016 | -16.86% |
| Dec 31, 2015 | 20.42% |
| Sep 30, 2015 | 28.14% |